Ontology highlight
ABSTRACT:
SUBMITTER: Hammaker D
PROVIDER: S-EPMC2911016 | biostudies-other | 2010 Jan
REPOSITORIES: biostudies-other
Annals of the rheumatic diseases 20100101
Despite the success of biological therapies in rheumatoid arthritis (RA), orally active small-molecule drugs are desirable. Signal transduction inhibitors have been the focus of intense efforts, with some recent notable successes and failures. p38alpha is a signalling molecule that regulates proinflammatory cytokines, which makes it a logical target for RA. Unfortunately, selective p38alpha inhibitors have limited efficacy. An attempt is made here to put these studies into perspective and offer ...[more]